Literature DB >> 24709888

Rare SF3B1 R625 mutations in cutaneous melanoma.

Yong Kong1, Michael Krauthammer, Ruth Halaban.   

Abstract

RNA splicing is the cellular process that has only recently been found to be an important target for various cancers. Among the spliceosome genes that are involved in cancers, SF3B1 is most frequently mutated. Recurrent mutation in codon 625 has been found in uveal melanoma, but this mutation has not been identified in cutaneous melanoma. We used whole-exome sequencing to explore the mutational landscape of 295 melanoma samples, 231 of which are cutaneous melanoma. Among these cutaneous melanoma samples, we found two samples with R625 mutation in SF3B1 gene. The results were validated by Sanger sequencing. We conclude that SF3B1 R625 mutation does occur in cutaneous melanoma, although with a low frequency (∼1%).

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24709888      PMCID: PMC4101881          DOI: 10.1097/CMR.0000000000000071

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.199


  9 in total

Review 1.  Lessons from the cancer genome.

Authors:  Levi A Garraway; Eric S Lander
Journal:  Cell       Date:  2013-03-28       Impact factor: 41.582

2.  Genetic and clinico-pathologic analysis of metastatic uveal melanoma.

Authors:  Klaus G Griewank; Johannes van de Nes; Bastian Schilling; Iris Moll; Antje Sucker; Hojabr Kakavand; Lauren E Haydu; Marina Asher; Lisa Zimmer; Uwe Hillen; John F Thompson; Richard A Scolyer; Dirk Schadendorf; Rajmohan Murali
Journal:  Mod Pathol       Date:  2013-07-26       Impact factor: 7.842

3.  Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3.

Authors:  Marcel Martin; Lars Maßhöfer; Petra Temming; Sven Rahmann; Claudia Metz; Norbert Bornfeld; Johannes van de Nes; Ludger Klein-Hitpass; Alan G Hinnebusch; Bernhard Horsthemke; Dietmar R Lohmann; Michael Zeschnigk
Journal:  Nat Genet       Date:  2013-06-23       Impact factor: 38.330

4.  Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia.

Authors:  Víctor Quesada; Laura Conde; Neus Villamor; Gonzalo R Ordóñez; Pedro Jares; Laia Bassaganyas; Andrew J Ramsay; Sílvia Beà; Magda Pinyol; Alejandra Martínez-Trillos; Mónica López-Guerra; Dolors Colomer; Alba Navarro; Tycho Baumann; Marta Aymerich; María Rozman; Julio Delgado; Eva Giné; Jesús M Hernández; Marcos González-Díaz; Diana A Puente; Gloria Velasco; José M P Freije; José M C Tubío; Romina Royo; Josep L Gelpí; Modesto Orozco; David G Pisano; Jorge Zamora; Miguel Vázquez; Alfonso Valencia; Heinz Himmelbauer; Mónica Bayés; Simon Heath; Marta Gut; Ivo Gut; Xavier Estivill; Armando López-Guillermo; Xose S Puente; Elías Campo; Carlos López-Otín
Journal:  Nat Genet       Date:  2011-12-11       Impact factor: 38.330

5.  Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.

Authors:  E Papaemmanuil; M Cazzola; J Boultwood; L Malcovati; P Vyas; D Bowen; A Pellagatti; J S Wainscoat; E Hellstrom-Lindberg; C Gambacorti-Passerini; A L Godfrey; I Rapado; A Cvejic; R Rance; C McGee; P Ellis; L J Mudie; P J Stephens; S McLaren; C E Massie; P S Tarpey; I Varela; S Nik-Zainal; H R Davies; A Shlien; D Jones; K Raine; J Hinton; A P Butler; J W Teague; E J Baxter; J Score; A Galli; M G Della Porta; E Travaglino; M Groves; S Tauro; N C Munshi; K C Anderson; A El-Naggar; A Fischer; V Mustonen; A J Warren; N C P Cross; A R Green; P A Futreal; M R Stratton; P J Campbell
Journal:  N Engl J Med       Date:  2011-09-26       Impact factor: 91.245

6.  SF3B1 mutations are associated with alternative splicing in uveal melanoma.

Authors:  Marc-Henri Stern; Richard Marais; Simon J Furney; Malin Pedersen; David Gentien; Amaury G Dumont; Audrey Rapinat; Laurence Desjardins; Samra Turajlic; Sophie Piperno-Neumann; Pierre de la Grange; Sergio Roman-Roman
Journal:  Cancer Discov       Date:  2013-07-16       Impact factor: 39.397

7.  Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma.

Authors:  Michael Krauthammer; Yong Kong; Byung Hak Ha; Perry Evans; Antonella Bacchiocchi; James P McCusker; Elaine Cheng; Matthew J Davis; Gerald Goh; Murim Choi; Stephan Ariyan; Deepak Narayan; Ken Dutton-Regester; Ana Capatana; Edna C Holman; Marcus Bosenberg; Mario Sznol; Harriet M Kluger; Douglas E Brash; David F Stern; Miguel A Materin; Roger S Lo; Shrikant Mane; Shuangge Ma; Kenneth K Kidd; Nicholas K Hayward; Richard P Lifton; Joseph Schlessinger; Titus J Boggon; Ruth Halaban
Journal:  Nat Genet       Date:  2012-07-29       Impact factor: 38.330

8.  Lack of SF3B1 R625 mutations in cutaneous melanoma.

Authors:  Bastian Schilling; Nicola Bielefeld; Antje Sucker; Uwe Hillen; Lisa Zimmer; Dirk Schadendorf; Michael Zeschnigk; Klaus G Griewank
Journal:  Diagn Pathol       Date:  2013-05-21       Impact factor: 2.644

9.  Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma.

Authors:  J William Harbour; Elisha D O Roberson; Hima Anbunathan; Michael D Onken; Lori A Worley; Anne M Bowcock
Journal:  Nat Genet       Date:  2013-01-13       Impact factor: 38.330

  9 in total
  22 in total

1.  Identification of recurrent mutational events in anorectal melanoma.

Authors:  Hui Min Yang; Susan J Hsiao; David F Schaeffer; Chi Lai; Helen E Remotti; David Horst; Mahesh M Mansukhani; Basil A Horst
Journal:  Mod Pathol       Date:  2016-10-14       Impact factor: 7.842

2.  Primary malignant melanoma of esophagus: clinicopathologic characterization of 20 cases including molecular genetic profiling of 15 tumors.

Authors:  Jerzy Lasota; Artur Kowalik; Anna Felisiak-Golabek; Sebastian Zięba; Piotr Waloszczyk; Marek Masiuk; Jaroslaw Wejman; Justyna Szumilo; Markku Miettinen
Journal:  Mod Pathol       Date:  2019-02-13       Impact factor: 7.842

Review 3.  Alternative-splicing defects in cancer: Splicing regulators and their downstream targets, guiding the way to novel cancer therapeutics.

Authors:  Laura M Urbanski; Nathan Leclair; Olga Anczuków
Journal:  Wiley Interdiscip Rev RNA       Date:  2018-04-25       Impact factor: 9.957

4.  Functional and conformational impact of cancer-associated SF3B1 mutations depends on the position and the charge of amino acid substitution.

Authors:  Christine Canbezdi; Malcy Tarin; Alexandre Houy; Dorine Bellanger; Tatiana Popova; Marc-Henri Stern; Sergio Roman-Roman; Samar Alsafadi
Journal:  Comput Struct Biotechnol J       Date:  2021-02-27       Impact factor: 7.271

Review 5.  Splicing-factor alterations in cancers.

Authors:  Olga Anczuków; Adrian R Krainer
Journal:  RNA       Date:  2016-09       Impact factor: 4.942

6.  Whole-exome sequencing identifies recurrent SF3B1 R625 mutation and comutation of NF1 and KIT in mucosal melanoma.

Authors:  Jennifer D Hintzsche; Nicholas T Gorden; Carol M Amato; Jihye Kim; Kelsey E Wuensch; Steven E Robinson; Allison J Applegate; Kasey L Couts; Theresa M Medina; Keith R Wells; Joshua A Wisell; Martin D McCarter; Neil F Box; Yiqun G Shellman; Rene C Gonzalez; Karl D Lewis; John J Tentler; Aik Choon Tan; William A Robinson
Journal:  Melanoma Res       Date:  2017-06       Impact factor: 3.599

7.  Molecular Genetics of Conjunctival Melanoma and Prognostic Value of TERT Promoter Mutation Analysis.

Authors:  Natasha M van Poppelen; Jolique A van Ipenburg; Quincy van den Bosch; Jolanda Vaarwater; Tom Brands; Bert Eussen; Frank Magielsen; Hendrikus J Dubbink; Dion Paridaens; Erwin Brosens; Nicole Naus; Annelies de Klein; Emine Kiliç; Robert M Verdijk
Journal:  Int J Mol Sci       Date:  2021-05-28       Impact factor: 5.923

8.  Cancer-associated SF3B1 mutations affect alternative splicing by promoting alternative branchpoint usage.

Authors:  Samar Alsafadi; Alexandre Houy; Aude Battistella; Tatiana Popova; Michel Wassef; Emilie Henry; Franck Tirode; Angelos Constantinou; Sophie Piperno-Neumann; Sergio Roman-Roman; Martin Dutertre; Marc-Henri Stern
Journal:  Nat Commun       Date:  2016-02-04       Impact factor: 17.694

9.  SF3B1 and EIF1AX mutations occur in primary leptomeningeal melanocytic neoplasms; yet another similarity to uveal melanomas.

Authors:  Heidi V N Küsters-Vandevelde; David Creytens; Adriana C H van Engen-van Grunsven; Marcel Jeunink; Veronique Winnepenninckx; Patricia J T A Groenen; Benno Küsters; Pieter Wesseling; Willeke A M Blokx; Clemens F M Prinsen
Journal:  Acta Neuropathol Commun       Date:  2016-01-15       Impact factor: 7.801

10.  Multiple primary malignancies and prolonged survival in a patient with widespread metastatic cutaneous melanoma.

Authors:  Anna M Rose; Utsav K Radia; Rong Luo; Helen Kalirai; Channa N Jayasena; Philip Luthert; Sarah E Coupland; Geoffrey E Rose
Journal:  Melanoma Res       Date:  2018-04       Impact factor: 3.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.